Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
FY2025 Q3 Financial Results (Material)
HEALIOS, Jan-Sep (Cumulative 3Q) Net Income Loss Narrows, Jul-Sep Net Income Turns to Profit
Healios K.K. to Present at Jefferies Global Healthcare Conference
Announcement of Subgroup Analysis Results from the MUST-ARDS Trial Regarding Kidney Dysfunction
Healios K.K. to Present at Chardan's 9th Annual Genetic Medicines Conference
Notice of Joint Research Agreement with Kyushu University on Immuno-Cell Therapy for Brain Tumors Using Healios’ Gene-Edited CAR-eNK Cells
Notice Regarding the Termination of the Business and Capital Alliance Agreement with Nikon Corporation
Collaboration Between Minaris Advanced Therapies and Healios for the Commercial Manufacturing of Invimestrocel
Announcement of UDC Patent Approval (Japan)
FY2025 Q2 Financial Results (Material)
HEALIOS, First Half Net Income Loss Widens, Apr-Jun Net Income Loss Widens
Academic Paper on eNK Cells in "Stem Cell Research and Therapy" -Human iPSC-derived NK cells armed with the six transgenes-
Selection for“Subsidy Program to Support Capital Investment in Regenerative, Cell, and Gene Therapy Manufacturing Facilities” by METI
Healios to Present at the 2025 Jefferies Global Healthcare Conference
FY2025 Q1 Financial Results (Material)
HEALIOS, Jan-Mar (1Q) Net Income Loss Widens
FY2025 Q1 Financial Results (Material)
FY2025 Q1 Financial Results (Material)
FY2025 Q1 Financial Results (Material)
Decision Regarding Policy to File for Conditional and Time-Limited Approval of Ischemic Stroke Treatment in Japan and Development Strategy Overview